继发性高氨血症：丙戊酸脑病的一种可能机制。 - Suppr

Suppr

超能文献

Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.

作者信息

Coulter D L, Allen R J

出版信息

Lancet. 1980 Jun 14;1(8181):1310-1. doi: 10.1016/s0140-6736(80)91773-0.

DOI:10.1016/s0140-6736(80)91773-0

PMID:6104123

Abstract

摘要

相似文献

Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.

Lancet. 1980 Jun 14;1(8181):1310-1. doi: 10.1016/s0140-6736(80)91773-0.

Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.

Neurology. 2000 Jan 11;54(1):230-2. doi: 10.1212/wnl.54.1.230.

[A case report of valproate encephalopathy].

Rinsho Shinkeigaku. 1999 Oct;39(10):1075-7.

Non-hyperammonaemia valproate-induced encephalopathy: A case report.

J Clin Pharm Ther. 2022 Mar;47(3):415-419. doi: 10.1111/jcpt.13511. Epub 2021 Aug 31.

[Hyperammonemic encephalopathy associated with valproate acid].

Neurologia. 2003 Jul-Aug;18(6):347-50.

Lesson of the month 1: Sodium valproate-induced encephalopathy.

Clin Med (Lond). 2018 Oct;18(5):430-432. doi: 10.7861/clinmedicine.18-5-430.

Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia.

Neurologist. 2018 Mar;23(2):51-52. doi: 10.1097/NRL.0000000000000166.

[Encephalopathy with asterixis induced by sodium valproate. Role of hyperammonemia without hepatic insufficiency].

Presse Med. 1985 Feb 16;14(7):431.

[Encephalopathy associated with hyperammonemia in an alcoholic patient treated with sodium valproate].

Gastroenterol Clin Biol. 1993;17(6-7):516-7.

[Encephalopathies caused by valproate].

Fortschr Neurol Psychiatr. 1999 Jan;67(1):7-11. doi: 10.1055/s-2007-993732.

引用本文的文献

Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy.

Biomolecules. 2025 Apr 15;15(4):588. doi: 10.3390/biom15040588.

Valproate encephalopathy: Case series and literature review.

SAGE Open Med Case Rep. 2024 Jun 20;12:2050313X241260152. doi: 10.1177/2050313X241260152. eCollection 2024.

Valproate induced carnitine deficiency and hyperammonaemia.

Clin Med (Lond). 2023 Jul;23(4):429. doi: 10.7861/clinmed.Let.23.4.1.

Extrahepatic portosystemic shunts as an unusual but treatable cause of hyperammonemic encephalopathy in a noncirrhotic patient - a case report.

Ther Adv Neurol Disord. 2022 May 14;15:17562864221097614. doi: 10.1177/17562864221097614. eCollection 2022.

Influence of Different Antiepileptic Drugs on Blood Ammonia and Homocysteine Levels in Children with Epilepsy.

Evid Based Complement Alternat Med. 2021 Oct 4;2021:5698765. doi: 10.1155/2021/5698765. eCollection 2021.

Rapid Rescue From Hyperammonemic Coma After Valproic Acid Poisoning: Dual Therapy With Continuous Renal Replacement Therapy and L-Carnitine Supplementation.

Cureus. 2021 Jun 27;13(6):e15968. doi: 10.7759/cureus.15968. eCollection 2021 Jun.

Multifactorial Effects on Different Types of Brain Cells Contribute to Ammonia Toxicity.

Neurochem Res. 2017 Mar;42(3):721-736. doi: 10.1007/s11064-016-1966-1. Epub 2016 Jun 10.

Non-Hyperammonemic valproate encephalopathy.

Ann Neurosci. 2014 Apr;21(2):76-9. doi: 10.5214/ans.0972.7531.210210.

Hyperammonemia associated with valproic acid concentrations.

Biomed Res Int. 2014;2014:217269. doi: 10.1155/2014/217269. Epub 2014 Apr 29.

A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver.

CMAJ. 2007 Sep 11;177(6):568-9. doi: 10.1503/cmaj.061272.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.

作者信息

Coulter D L, Allen R J

出版信息

Lancet. 1980 Jun 14;1(8181):1310-1. doi: 10.1016/s0140-6736(80)91773-0.

DOI:10.1016/s0140-6736(80)91773-0

PMID:6104123

Abstract

摘要

相似文献

Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.

Lancet. 1980 Jun 14;1(8181):1310-1. doi: 10.1016/s0140-6736(80)91773-0.

Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.

Neurology. 2000 Jan 11;54(1):230-2. doi: 10.1212/wnl.54.1.230.

[A case report of valproate encephalopathy].

Rinsho Shinkeigaku. 1999 Oct;39(10):1075-7.

Non-hyperammonaemia valproate-induced encephalopathy: A case report.

J Clin Pharm Ther. 2022 Mar;47(3):415-419. doi: 10.1111/jcpt.13511. Epub 2021 Aug 31.

[Hyperammonemic encephalopathy associated with valproate acid].

Neurologia. 2003 Jul-Aug;18(6):347-50.

Lesson of the month 1: Sodium valproate-induced encephalopathy.

Clin Med (Lond). 2018 Oct;18(5):430-432. doi: 10.7861/clinmedicine.18-5-430.

Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia.

Neurologist. 2018 Mar;23(2):51-52. doi: 10.1097/NRL.0000000000000166.

[Encephalopathy with asterixis induced by sodium valproate. Role of hyperammonemia without hepatic insufficiency].

Presse Med. 1985 Feb 16;14(7):431.

[Encephalopathy associated with hyperammonemia in an alcoholic patient treated with sodium valproate].

Gastroenterol Clin Biol. 1993;17(6-7):516-7.

[Encephalopathies caused by valproate].

Fortschr Neurol Psychiatr. 1999 Jan;67(1):7-11. doi: 10.1055/s-2007-993732.

引用本文的文献

Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy.

Biomolecules. 2025 Apr 15;15(4):588. doi: 10.3390/biom15040588.

Valproate encephalopathy: Case series and literature review.

SAGE Open Med Case Rep. 2024 Jun 20;12:2050313X241260152. doi: 10.1177/2050313X241260152. eCollection 2024.

Valproate induced carnitine deficiency and hyperammonaemia.

Clin Med (Lond). 2023 Jul;23(4):429. doi: 10.7861/clinmed.Let.23.4.1.

Extrahepatic portosystemic shunts as an unusual but treatable cause of hyperammonemic encephalopathy in a noncirrhotic patient - a case report.

Ther Adv Neurol Disord. 2022 May 14;15:17562864221097614. doi: 10.1177/17562864221097614. eCollection 2022.

Influence of Different Antiepileptic Drugs on Blood Ammonia and Homocysteine Levels in Children with Epilepsy.

Evid Based Complement Alternat Med. 2021 Oct 4;2021:5698765. doi: 10.1155/2021/5698765. eCollection 2021.

Rapid Rescue From Hyperammonemic Coma After Valproic Acid Poisoning: Dual Therapy With Continuous Renal Replacement Therapy and L-Carnitine Supplementation.

Cureus. 2021 Jun 27;13(6):e15968. doi: 10.7759/cureus.15968. eCollection 2021 Jun.

Multifactorial Effects on Different Types of Brain Cells Contribute to Ammonia Toxicity.

Neurochem Res. 2017 Mar;42(3):721-736. doi: 10.1007/s11064-016-1966-1. Epub 2016 Jun 10.

Non-Hyperammonemic valproate encephalopathy.

Ann Neurosci. 2014 Apr;21(2):76-9. doi: 10.5214/ans.0972.7531.210210.

Hyperammonemia associated with valproic acid concentrations.

Biomed Res Int. 2014;2014:217269. doi: 10.1155/2014/217269. Epub 2014 Apr 29.

A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver.

CMAJ. 2007 Sep 11;177(6):568-9. doi: 10.1503/cmaj.061272.